RVX-208 a Selective Bromodomain and Extra-terminal BET Protein Inhibitor Acts on Several Pathways to Benefit Cardiovascular Risks

被引：0
|
作者：
Wong, Norman C.
Kulikowski, Ewelina
Wasiak, Sylwia
Gilham, Dean
Halliday, Christopher
Lebioda, Kenneth
Sweeney, Mike
Johansson, Jan
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
Epigenetics; Inflammation; Complement HDL; Acute phase reactants;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17127
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [1] RVX-208 THE FIRST SELECTIVE BROMODOMAIN EXTRA-TERMINAL PROTEIN INHIBITOR BEING DEVELOPED FOR PATIENTS WITH HIGH RESIDUAL RISKS OF CARDIOVASCULAR DISEASE
    Wong, Norman Cw
    Johansson, Jan
    Lebioda, Kenneth
    Halliday, Christopher
    Kulikowski, Ewelina
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A258 - A258
  • [2] RVX-208 A SELECTIVE BROMODOMAIN EXTRA-TERMINAL PROTEIN INHIBITOR REDUCES MACE IN PATIENTS WITH HIGH RESIDUAL RISKS OF CARDIOVASCULAR DISEASE, A POST-HOC ANALYSIS
    Wong, N. C. W.
    Johansson, J. O.
    Lebioda, K.
    Halliday, C.
    Kulikowski, E.
    ATHEROSCLEROSIS, 2015, 241 (01) : E8 - E8
  • [3] APABETALONE (RVX-208), A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, DECREASES ABUNDANCE AND ACTIVITY OF COMPLEMENT PROTEINS IN VITRO, IN MICE AND IN CLINICAL STUDIES
    Wong, Norman Cw
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Wasiak, Sylwia
    Gilham, Dean
    Halliday, Christopher
    Sweeney, Mike
    Johansson, Jan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 109 - 109
  • [4] ANTI-ATHEROSCLEROTIC AND ANTI-INFLAMMATORY EFFECTS OF A NOVEL BROMODOMAIN EXTRA-TERMINAL (BET) PROTEIN INHIBITOR RVX-208, IN HYPERLIPIDEMIC APOE DEFICIENT MICE AND HUMANS
    Jahagirdar, R.
    Azhar, S.
    Attwell, S.
    Kulikowski, E.
    Sweeney, M.
    Johansson, J.
    Wong, N. C. W.
    CARDIOLOGY, 2015, 132 : 83 - 83
  • [5] RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
    Picaud, Sarah
    Wells, Christopher
    Felletar, Ildiko
    Brotherton, Deborah
    Martin, Sarah
    Savitsky, Pavel
    Diez-Dacal, Beatriz
    Philpott, Martin
    Bountra, Chas
    Lingard, Hannah
    Fedorov, Oleg
    Mueller, Susanne
    Brennan, Paul E.
    Knapp, Stefan
    Filippakopoulos, Panagis
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (49) : 19754 - 19759
  • [6] Anti-Atherosclerotic and Anti-Inflammatory Effects of a Novel Bromodomain Extra-Terminal (Bet) Protein Inhibitor Rvx-208, in Hyperlipidemic Apoe Deficient Mice and in Human Trials
    Jahagirdar, R.
    Attwell, S.
    Azhar, S.
    Kulikowski, E.
    Sweeney, M.
    Johansson, J.
    Wong, N. C. W.
    CORONARY ARTERY DISEASE 2015, 2016, : 57 - 60
  • [7] Selective BET inhibitor RVX-208 ameliorates periodontal inflammation and bone loss
    Sun, Mingxu
    Clayton, Nicholas
    Alam, Sheikh
    Asmussen, Niels
    Wong, Andrew
    Kim, Jin Ha
    Luong, Gary
    Mokhtari, Sasan
    Pellei, David
    Carrico, Caroline K.
    Schwartz, Zvi
    Boyan, Barbara D.
    Giannobile, William V.
    Sahingur, Sinem Esra
    Lin, Zhao
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2023, 50 (12) : 1658 - 1669
  • [8] A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice
    Jahagirdar, Ravi
    Zhang, Haiyan
    Azhar, Salman
    Tobin, Jennifer
    Attwell, Sarah
    Yu, Raymond
    Wu, Jin
    McLure, Kevin G.
    Hansen, Henrik C.
    Wagner, Gregory S.
    Young, Peter R.
    Srivastava, Rai Ajit K.
    Wong, Norman C. W.
    Johansson, Jan
    ATHEROSCLEROSIS, 2014, 236 (01) : 91 - 100
  • [9] Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)
    Sylwia Wasiak
    Dean Gilham
    Laura M. Tsujikawa
    Christopher Halliday
    Cyrus Calosing
    Ravi Jahagirdar
    Jan Johansson
    Michael Sweeney
    Norman C. Wong
    Ewelina Kulikowski
    Journal of Cardiovascular Translational Research, 2017, 10 : 337 - 347
  • [10] Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)
    Wasiak, Sylwia
    Gilham, Dean
    Tsujikawa, Laura M.
    Halliday, Christopher
    Calosing, Cyrus
    Jahagirdar, Ravi
    Johansson, Jan
    Sweeney, Michael
    Wong, Norman C.
    Kulikowski, Ewelina
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2017, 10 (04) : 337 - 347
12345